In general, the MVD has been quantified by immunohistochemical staining of tumor blood vessels with the use of antibodies, including CD31, CD34, von Willebrand Factor (vWF) or Factor VIII-related antigen (FVIII) and CD105. Here, VWF is linked to neoplasm.